Innocan Pharma INNPF Ratios (2024-2025)

OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST
Reported Financials

Innocan Pharma Quarterly Ratios

Periods 8 quarters
Latest Dec 2025

Innocan Pharma reported a gross margin of 88.81% and a net margin of 55.69% for the quarter ended Dec 2025. These financial ratios cover 8 quarters of results from Mar 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin 88.67%92.53%90.20%81.63%91.26%88.42%90.75%88.81%
EBT Margin -18.03%16.59%8.14%0.06%0.42%-1.56%-20.99%31.94%
EBIT Margin -17.91%6.15%4.08%29.16%6.27%5.65%-17.85%31.84%
EBITDA Margin -17.76%6.27%4.19%29.27%6.40%5.78%-17.69%32.08%
Operating Margin -17.91%6.15%4.08%29.16%6.27%5.65%-17.85%31.84%
Net Margin -21.48%3.90%-3.36%36.70%-2.94%-8.42%-28.54%55.69%
FCF Margin -11.01%7.84%-11.56%0.07%4.78%9.81%0.38%0.12%
Efficiency
Assets AverageAssets Avg. 10.04M10.93M11.08M10.82M
Equity AverageEquity Avg. 4.92M4.44M4.03M4.73M
Asset Utilization RatioAsset Util. 3.032.642.442.46
Leverage & Solvency
Interest Coverage RatioInterest Cover 39.1110.71-10.5937.81
Times Interest Earned 39.1110.71-10.5937.81
Return Ratios
Return on Sales [ROS]ROS -17.91%6.15%4.08%29.16%6.27%5.65%-17.85%31.84%
Return on Capital Employed [ROCE]ROCE 39.78%35.27%15.30%13.26%
Return on Assets [ROA]ROA 9.59%-2.82%-20.26%-3.15%
Return on Equity [ROE]ROE 19.56%-6.93%-55.68%-7.21%

Innocan Pharma Ratios API

Pull Innocan Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INNPF&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY